Levocarnitine and Coq10 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levocarnitine (levocarnitine) and Coq10 (coenzyme q - 10). Common drug interactions include pruritus among females and adverse event among males.

The phase IV clinical study analyzes what interactions people have when they take Levocarnitine and Coq10. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Levocarnitine?

Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 3,332 Levocarnitine users. Check the latest studies of Levocarnitine.

What is Coq10?

Coq10 has active ingredients of coenzyme q - 10. It is often used in high blood cholesterol. eHealthMe is studying from 10,401 Coq10 users. Check the latest studies of Coq10.



On Aug, 10, 2026

16 people who take Levocarnitine and Coq10 together, and have interactions are studied.

Levocarnitine and Coq10 drug interactions.

What are the common drug interactions of Levocarnitine and Coq10, by gender? *:

female:

  1. Pruritus (severe itching of the skin)
  2. Dizziness
  3. Headache (pain in head)
  4. Hypotension (abnormally low blood pressure)
  5. Migraine (headache)
  6. Peripheral swelling
  7. Unresponsive to stimuli
  8. Abasia (inability to walk)
  9. Abdominal distension
  10. Abdominal pain

male:

  1. Adverse event
  2. Blindness
  3. Rash pruritic (redness with itching)
  4. Red blood cell count decreased
  5. Vitamin b6 deficiency
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Migraine (headache)
  8. Ammonia increased
  9. Depressed level of consciousness
  10. Eye pruritus (eye itching)

What are the common drug interactions of Levocarnitine and Coq10, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Abasia (inability to walk)
  2. Abdominal distension
  3. Abdominal pain
  4. Ammonia increased
  5. Depressed level of consciousness
  6. Flatulence (flatus expelled through the anus)
  7. Head lag (weak head and neck control)
  8. Muscular weakness (muscle weakness)
  9. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  10. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

10-19:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Migraine (headache)
  3. Hypoglycaemia (deficiency of glucose in the bloodstream)
  4. Staring (a prolonged gaze or fixed look)
  5. Unresponsive to stimuli

20-29:

n/a

30-39:

n/a

40-49:

  1. Asthma
  2. Blindness
  3. Choking (mechanical obstruction of the flow of air from the environment into the lungs)
  4. Dizziness
  5. Eye pain
  6. Fatigue (feeling of tiredness)
  7. Headache (pain in head)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Hypotension (abnormally low blood pressure)
  10. Oropharyngeal spasm (contraction of oropharynx)

50-59:

  1. Eye pain
  2. Mitochondrial toxicity (a condition in which the mitochondria of a body's cells become damaged or decline significantly in number;)
  3. Mobility decreased (ability to move is reduced)
  4. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  5. Neuropathy peripheral (surface nerve damage)
  6. Peripheral swelling
  7. Rash pruritic (redness with itching)
  8. Red blood cell count decreased
  9. Vitamin b6 deficiency
  10. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)

60+:

  1. Diarrhoea
  2. Hot flush (sudden feelings of heat)
  3. Pigmentation disorder (disturbances of human skin colour)
  4. Pruritus (severe itching of the skin)
  5. Weight increased

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 3 people, 18.75%
  2. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 12.50%
  3. Stress And Anxiety: 1 person, 6.25%
  4. Herpes Virus Infection: 1 person, 6.25%
  5. Arrhythmias (irregular heartbeat): 1 person, 6.25%
  6. Asthma: 1 person, 6.25%
  7. Cardiac Failure: 1 person, 6.25%
  8. Cystinosis (abnormal accumulation of the amino acid cystine): 1 person, 6.25%
  9. Depression: 1 person, 6.25%
  10. Diabetes: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Levocarnitine and Coq10?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Levocarnitine and Coq10:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levocarnitine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Coq10:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levocarnitine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Coq10 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on levocarnitine and coenzyme q - 10 (the active ingredients of Levocarnitine and Coq10, respectively), and Levocarnitine and Coq10 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: